Similarly, modulating the parent cells to prevent the incorporation of deleterious proteins or miRNAs, such as toxic tau or α-synuclein, in the MGEVs could help mitigate the progression of neurodegenerative diseases like AD and PD. This evidence concerns the gene SNCA and Parkinson disease.